González-Foruria Iñaki, Santulli Pietro, Chouzenoux Sandrine, Carmona Francisco, Batteux Frédéric, Chapron Charles
Département Développement, Reproduction et Cancer, Institut Cochin, INSERM, Paris, France; Université Paris Descartes, Sorbone Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire (GHU) Ouest, Centre Hospitalier Universitaire (CHU) Cochin, Department of Gynecology Obstetrics II and Reproductive Medicine, Paris, France; Institut Clinic of Gynecology, Obstetrics and Neonatology, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine-University of Barcelona, Barcelona, Spain.
Département Développement, Reproduction et Cancer, Institut Cochin, INSERM, Paris, France; Université Paris Descartes, Sorbone Paris Cité, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire (GHU) Ouest, Centre Hospitalier Universitaire (CHU) Cochin, Department of Gynecology Obstetrics II and Reproductive Medicine, Paris, France.
PLoS One. 2015 Mar 16;10(3):e0119961. doi: 10.1371/journal.pone.0119961. eCollection 2015.
Endometriosis is a benign gynaecological disease. Abundant bulk of evidence suggests that patients with endometriosis have an immunity dysfunction that enables ectopic endometrial cells to implant and proliferate. Previous studies show that natural killer cells have a pivotal role in the immune control of endometriosis.
This is a prospective laboratory study conducted in a tertiary-care university hospital between January 2011 and April 2013. We investigated non-pregnant, younger than 42-year-old patients (n= 202) during surgery for benign gynaecological conditions. After complete surgical exploration of the abdominopelvic cavity, 121 women with histologically proven endometriosis and 81 endometriosis-free controls women were enrolled. Patients with endometriosis were classified according to a surgical classification in three different types of endometriosis: superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA) and deep infiltrating endometriosis (DIE). Peritoneal fluid samples were obtained from all study participants during the surgery in order to detect soluble NKG2D ligands (MICA, MICB and ULBP-2). When samples with undetectable peritoneal fluid levels of MICA, MICB and ULBP-2 were excluded, MICA ratio levels were significantly higher in endometriosis patients than in controls (median, 1.1 pg/mg; range, 0.1-143.5 versus median, 0.6 pg/mg; range, 0.1-3.5; p=0.003). In a similar manner peritoneal fluid MICB levels were also increased in endometriosis-affected patients compared with disease-free women (median, 4.6 pg/mg; range, 1.2-4702 versus median, 3.4 pg/mg; range, 0.7-20.1; p=0.001). According to the surgical classification, peritoneal fluid soluble MICA, MICB and ULBP-2 ratio levels were significantly increased in DIE as compared to controls (p=0.015, p=0.003 and p=0.045 respectively). MICA ratio levels also correlated with dysmenorrhea (r=0.232; p=0.029), total rAFS score (r=0.221; p=0.031) and adhesions rAFS score (r=0.221; p=0.031).
We demonstrate a significant increase of peritoneal fluid NKG2D ligands in women with endometriosis especially in those cases presenting DIE. This study suggests that NKG2D ligands shedding is a novel pathway in endometriosis complex pathogenesis that impairs NK cell function.
子宫内膜异位症是一种良性妇科疾病。大量证据表明,子宫内膜异位症患者存在免疫功能障碍,使得异位子宫内膜细胞能够着床并增殖。既往研究表明,自然杀伤细胞在子宫内膜异位症的免疫控制中起关键作用。
这是一项前瞻性实验室研究,于2011年1月至2013年4月在一家三级大学附属医院进行。我们在对患有良性妇科疾病的患者进行手术期间,调查了年龄小于42岁的非妊娠患者(n = 202)。在对腹腔进行全面手术探查后,纳入了121例经组织学证实患有子宫内膜异位症的女性和81例无子宫内膜异位症的对照女性。患有子宫内膜异位症的患者根据手术分类被分为三种不同类型的子宫内膜异位症:浅表性腹膜子宫内膜异位症(SUP)、卵巢子宫内膜异位囊肿(OMA)和深部浸润性子宫内膜异位症(DIE)。在手术期间从所有研究参与者中获取腹腔液样本,以检测可溶性NKG2D配体(MICA、MICB和ULBP - 2)。当排除腹腔液中MICA、MICB和ULBP - 2水平检测不到的样本后,子宫内膜异位症患者的MICA比率水平显著高于对照组(中位数,1.1 pg/mg;范围,0.1 - 143.5,而对照组中位数为0.6 pg/mg;范围,0.1 - 3.5;p = 0.003)。同样,与未患该病的女性相比,受子宫内膜异位症影响的患者腹腔液中的MICB水平也有所升高(中位数,4.6 pg/mg;范围,1.2 - 4702,而对照组中位数为3.4 pg/mg;范围,0.7 - 20.1;p = 0.001)。根据手术分类,与对照组相比,DIE患者腹腔液中可溶性MICA、MICB和ULBP - 2比率水平显著升高(分别为p = 0.015、p = 0.003和p = 0.045)。MICA比率水平还与痛经(r = 0.232;p = 0.029)、总rAFS评分(r = 0.221;p = 0.031)和粘连rAFS评分(r = 0.221;p = 0.031)相关。
我们证明了子宫内膜异位症女性腹腔液中NKG2D配体显著增加,尤其是在那些表现为DIE的病例中。这项研究表明,NKG2D配体脱落是子宫内膜异位症复杂发病机制中的一条新途径,它损害了自然杀伤细胞的功能。